• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用单克隆抗体大规模纯化人组织型纤溶酶原激活剂。

Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.

作者信息

Einarsson M, Brandt J, Kaplan L

出版信息

Biochim Biophys Acta. 1985 Jul 18;830(1):1-10. doi: 10.1016/0167-4838(85)90123-2.

DOI:10.1016/0167-4838(85)90123-2
PMID:4040396
Abstract

Tissue plasminogen activator produced by a human melanoma cell line (Bowes), was purified from large volumes of supernatant fluid using immunosorbent chromatography on monoclonal antibodies, followed by chromatography on lysine-Sepharose 4B and gel filtration on Sephadex G-150. Immunosorbents based on monoclonal antibodies were shown to be preferable to those based on polyclonal antibodies for several reasons: efficient binding and desorption, high yield along with a high degree of purification. The overall recovery was about 50%. A homogeneous sample of single-chain tissue plasminogen activator with a molecular weight of approx. 65 000 was obtained as judged by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate. Amino acid sequence analysis revealed two N-terminals in equal yields, corresponding to the long and short tissue plasminogen activator structures previously reported by others. The pure preparations of tissue plasminogen activator showed specific activities of about 200 000 IU/mg protein.

摘要

从人黑色素瘤细胞系(鲍伊斯细胞系)产生的组织型纤溶酶原激活剂,是通过以下步骤从大量上清液中纯化得到的:先用单克隆抗体进行免疫吸附色谱,然后用赖氨酸-琼脂糖4B进行色谱分离,最后用葡聚糖凝胶G-150进行凝胶过滤。基于单克隆抗体的免疫吸附剂由于几个原因而被证明比基于多克隆抗体的免疫吸附剂更可取:结合和解吸效率高、产量高且纯化程度高。总体回收率约为50%。通过十二烷基硫酸钠存在下的聚丙烯酰胺凝胶电泳判断,获得了分子量约为65000的单链组织型纤溶酶原激活剂的均一样品。氨基酸序列分析显示有两个N末端,产量相等,对应于其他人先前报道的长型和短型组织型纤溶酶原激活剂结构。组织型纤溶酶原激活剂的纯制剂显示出约200000 IU/mg蛋白质的比活性。

相似文献

1
Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.使用单克隆抗体大规模纯化人组织型纤溶酶原激活剂。
Biochim Biophys Acta. 1985 Jul 18;830(1):1-10. doi: 10.1016/0167-4838(85)90123-2.
2
Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.从大鼠吉田腹水肉瘤中分离纯化纤溶酶原激活剂。
Indian J Biochem Biophys. 1991 Feb;28(1):46-51.
3
Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.猪肾细胞系分泌的纤溶酶原激活物的纯化及特性分析
Biochem J. 1984 May 1;219(3):971-8. doi: 10.1042/bj2190971.
4
Purification and characterization of a melanoma cell plasminogen activator.一种黑色素瘤细胞纤溶酶原激活剂的纯化与特性分析
Eur J Biochem. 1983 May 16;132(3):681-6. doi: 10.1111/j.1432-1033.1983.tb07418.x.
5
Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.从人黑色素瘤细胞系的条件培养基中纯化一种与内皮型纤溶酶原激活物抑制剂具有免疫相关性的活性纤溶酶原激活物抑制剂。
J Biol Chem. 1986 Nov 5;261(31):14474-81.
6
Purification and partial characterization of plasminogen activator from human uterine tissue.
Biochim Biophys Acta. 1979 Sep 29;580(1):140-53. doi: 10.1016/0005-2795(79)90205-8.
7
Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.从人细胞培养物中纯化和鉴定单链尿激酶型纤溶酶原激活剂
J Biol Chem. 1986 Jan 25;261(3):1274-8.
8
Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.从培养的大鼠前列腺腺癌细胞中提取纤溶酶原激活剂及其性质
Biochemistry. 1983 Sep 13;22(19):4444-9. doi: 10.1021/bi00288a015.
9
Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.培养的人黑色素瘤细胞分泌的纤溶酶原激活物的纯化及特性分析
J Biol Chem. 1981 Jul 10;256(13):7035-41.
10
[Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].[从人胚肺成纤维细胞培养物中分离尿激酶型纤溶酶原激活剂及其特性]
Mol Biol (Mosk). 1986 May-Jun;20(3):778-88.

引用本文的文献

1
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival.组织型纤溶酶原激活剂(tPA)对神经元存活的影响。
Front Cell Neurosci. 2015 Oct 16;9:415. doi: 10.3389/fncel.2015.00415. eCollection 2015.
2
Carbohydrate analysis throughout the development of a protein therapeutic.在蛋白质治疗药物的整个开发过程中进行碳水化合物分析。
Glycoconj J. 2010 Feb;27(2):211-25. doi: 10.1007/s10719-009-9261-x. Epub 2009 Nov 4.
3
The glycosylation of Bowes melanoma tissue plasminogen activator: lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycans.
鲍伊斯黑色素瘤组织纤溶酶原激活物的糖基化:凝集素图谱分析、与抗L2/HNK-1抗体的反应以及含硫酸化/葡萄糖醛酸聚糖的存在
Biochem J. 1996 Jun 1;316 ( Pt 2)(Pt 2):427-37. doi: 10.1042/bj3160427.
4
Immunoaffinity chromatography.免疫亲和层析
Mol Biotechnol. 1994 Feb;1(1):59-86. doi: 10.1007/BF02821511.
5
Separation and characterization of the two Asn-linked glycosylation sites of chicken serum riboflavin-binding protein. Glycosylation differences despite similarity of primary structure.鸡血清核黄素结合蛋白两个天冬酰胺连接的糖基化位点的分离与鉴定。尽管一级结构相似,但糖基化存在差异。
Biochem J. 1992 Jul 1;285 ( Pt 1)(Pt 1):275-80. doi: 10.1042/bj2850275.
6
Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.由于糖基化增加,重组抗凝血酶对肝素的亲和力降低。
Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):793-800. doi: 10.1042/bj2860793.